Natural Plant Bioactives as Regulators of Histone Modifications: Bridging Epigenetics and Anticancer Therapy
Phytotherapy Research · 2026-08 · 40 (8) · 5208-5254
DOI: 10.1002/ptr.70386 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, published online on 2026-05-25. Written by Mengxiao Wang and 6 co-authors. Institution: Heilongjiang University of Chinese Medicine, Harbin, China. Major MEDLINE topics: Epigenesis, Genetic, Histones, Neoplasms, Biological Products. Cited 1 times so far (Crossref); 248 references. The full text is freely available in PubMed Central. Funded by: National Natural Science Foundation of China, Research Projects of the Heilongjiang Provincial Administration of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine funded projects.
Abstract (original language)
Cancer remains a leading cause of global mortality, with tumor heterogeneity, recurrence, metastasis, and drug resistance posing significant challenges to conventional therapies, which are often limited by toxicity and efficacy. Epigenetic regulation, particularly histone modifications such as methylation, acetylation, phosphorylation, and lactylation, plays a pivotal role in orchestrating gene expression and tumor progression, representing promising yet complex therapeutic targets. Bioactive compounds derived from natural plants, characterized by multi‐target activity and low toxicity, have emerged as potent modulators of histone modifications, capable of influencing tumor growth, metastasis, and the tumor microenvironment. Here, we provide a comprehensive review of recent advances elucidating how natural products influence cancer progression and reshape the tumor immune microenvironment by regulating histone modifications. We integrate current knowledge of key histone marks, modifying enzymes, and signaling pathways, proposing a unified framework linking natural compounds, epigenetic regulation, and tumorigenesis. By uncovering these molecular mechanisms, we highlight that plant bioactive compounds can reshape the tumor immune microenvironment through histone modifications to inspire the development of novel, safer, and more effective anticancer agents.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Heilongjiang University of Chinese Medicine, Harbin, China.
- Graduate Department, Qiqihar Medical University, Qiqihar, Heilongjiang, China.
- Department of Medical Technology, Qiqihar Medical College, Qiqihar, China.
ORCID profiles: Mengxiao Wang, Junyi Liang
Funding
- National Natural Science Foundation of China
- Research Projects of the Heilongjiang Provincial Administration of Traditional Chinese Medicine
- Heilongjiang University of Chinese Medicine funded projects
Cite
APA
Wang, M., Liang, J., Zhu, X., Xing, Y., Chang, S., Jia, D., & Zhao, W. (2026). Natural Plant Bioactives as Regulators of Histone Modifications: Bridging Epigenetics and Anticancer Therapy. Phytotherapy Research, 40(8), 5208-5254. https://doi.org/10.1002/ptr.70386
Vancouver
Wang M, Liang J, Zhu X, Xing Y, Chang S, Jia D, et al. Natural Plant Bioactives as Regulators of Histone Modifications: Bridging Epigenetics and Anticancer Therapy. Phytotherapy Research. 2026;40(8):5208-5254. doi:10.1002/ptr.70386
BibTeX
@article{Wang2026,
author = {Wang, Mengxiao and Liang, Junyi and Zhu, Xinping and Xing, Yushuang and Chang, Shijun and Jia, Di and Zhao, Weiming},
title = {Natural Plant Bioactives as Regulators of Histone Modifications: Bridging Epigenetics and Anticancer Therapy},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {8},
pages = {5208--5254},
doi = {10.1002/ptr.70386}
}
EUVIMED